Innovating Works

MLLI GMBH

Desconocido
LeukoScreen: AI-based leukemia detection in routine diagnostic blood smear data MLLI GMBH participó en un HORIZON EUROPE: ERC-2022-POC2 Acute promyelocytic leukemia is an extremely aggressive blood cancer where immediate diagnosis can determine life or death. The diagnostic s...
2023-11-03 - 2025-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.